Campbell S.D. Roxburgh

9.2k total citations · 1 hit paper
143 papers, 4.8k citations indexed

About

Campbell S.D. Roxburgh is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Campbell S.D. Roxburgh has authored 143 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Oncology, 46 papers in Surgery and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Campbell S.D. Roxburgh's work include Colorectal Cancer Surgical Treatments (57 papers), Inflammatory Biomarkers in Disease Prognosis (54 papers) and Cancer Immunotherapy and Biomarkers (26 papers). Campbell S.D. Roxburgh is often cited by papers focused on Colorectal Cancer Surgical Treatments (57 papers), Inflammatory Biomarkers in Disease Prognosis (54 papers) and Cancer Immunotherapy and Biomarkers (26 papers). Campbell S.D. Roxburgh collaborates with scholars based in United Kingdom, United States and Canada. Campbell S.D. Roxburgh's co-authors include Donald C. McMillan, Paul G. Horgan, Graeme J.K. Guthrie, Stephen Clarke, Kellie A. Charles, James H. Park, Colin H. Richards, Alan K. Foulis, Stephen T. McSorley and Joanne Edwards and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Campbell S.D. Roxburgh

135 papers receiving 4.7k citations

Hit Papers

The systemic inflammation-based neutrophil–lymphocyte rat... 2013 2026 2017 2021 2013 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
    2013 1.2k citations Graeme J.K. Guthrie, Campbell S.D. Roxburgh et al. Critical Reviews in Oncology/Hematology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Campbell S.D. Roxburgh United Kingdom 34 3.5k 1.2k 884 837 564 143 4.8k
Dietmar Tamandl Austria 34 1.8k 0.5× 1.4k 1.2× 968 1.1× 257 0.3× 400 0.7× 110 4.0k
Jyrki Mäkelä Finland 36 2.5k 0.7× 2.4k 2.1× 826 0.9× 370 0.4× 356 0.6× 130 4.5k
Mototsugu Shimokawa Japan 34 2.1k 0.6× 861 0.7× 1.5k 1.7× 411 0.5× 362 0.6× 306 3.8k
Reiping Tang Taiwan 31 2.3k 0.6× 1.5k 1.3× 554 0.6× 486 0.6× 151 0.3× 117 3.6k
Thomas Aparicio France 40 3.6k 1.0× 1.8k 1.5× 2.1k 2.4× 866 1.0× 249 0.4× 254 6.5k
Jin‐Tung Liang Taiwan 35 2.2k 0.6× 1.4k 1.2× 974 1.1× 563 0.7× 202 0.4× 185 4.1k
Martin Rutegård Sweden 38 4.2k 1.2× 3.5k 3.0× 1.2k 1.4× 384 0.5× 453 0.8× 139 6.1k
Jungnam Joo South Korea 35 1.2k 0.3× 956 0.8× 1.2k 1.4× 539 0.6× 227 0.4× 188 4.0k
Gregory D. Ayers United States 30 1.2k 0.4× 1.0k 0.9× 625 0.7× 441 0.5× 351 0.6× 88 3.8k
Yasuo Sakamoto Japan 39 1.8k 0.5× 2.0k 1.7× 1.4k 1.6× 618 0.7× 167 0.3× 179 5.0k

Countries citing papers authored by Campbell S.D. Roxburgh

Since Specialization
Citations

This map shows the geographic impact of Campbell S.D. Roxburgh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Campbell S.D. Roxburgh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Campbell S.D. Roxburgh more than expected).

Fields of papers citing papers by Campbell S.D. Roxburgh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Campbell S.D. Roxburgh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Campbell S.D. Roxburgh. The network helps show where Campbell S.D. Roxburgh may publish in the future.

Co-authorship network of co-authors of Campbell S.D. Roxburgh

This figure shows the co-authorship network connecting the top 25 collaborators of Campbell S.D. Roxburgh. A scholar is included among the top collaborators of Campbell S.D. Roxburgh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Campbell S.D. Roxburgh. Campbell S.D. Roxburgh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McSorley, Stephen T., Donald McMillan, David Mansouri, et al.. (2025). Does robotic assisted surgery mitigate obesity related systemic inflammatory response and clinical outcomes in left sided colorectal cancer resections?. Journal of Robotic Surgery. 19(1). 98–98. 2 indexed citations
2.
Roxburgh, Campbell S.D., et al.. (2024). A systematic review of the role of systemic inflammation-based prognostic scores in patients with abdominal aortic aneurysm. The Surgeon. 23(1). e1–e8. 2 indexed citations
3.
McGovern, Josh, et al.. (2024). The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 199. 104378–104378. 6 indexed citations
4.
Williams, Christopher J.M., Pashtoon Murtaza Kasi, Jenny F. Seligmann, et al.. (2024). Author Correction: Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response. Nature Reviews Clinical Oncology. 21(12). 903–903. 2 indexed citations
5.
Williams, Christopher J.M., Pashtoon Murtaza Kasi, Jenny F. Seligmann, et al.. (2024). Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response. Nature Reviews Clinical Oncology. 21(12). 839–851. 25 indexed citations
6.
Ferguson, Michael J., Paul J. McMillan, David Mansouri, et al.. (2024). CT-derived body composition and differential association with age, TNM stage and systemic inflammation in patients with colon cancer. Scientific Reports. 14(1). 15673–15673. 1 indexed citations
7.
Knight, Katrina, Christopher Bigley, Kathryn A.F. Pennel, et al.. (2024). The Glasgow Microenvironment Score: an exemplar of contemporary biomarker evolution in colorectal cancer. The Journal of Pathology Clinical Research. 10(4). e12385–e12385. 2 indexed citations
8.
Roxburgh, Campbell S.D., et al.. (2024). Clinical effectiveness of robotic versus laparoscopic and open surgery: an overview of systematic reviews. BMJ Open. 14(9). e076750–e076750. 7 indexed citations
9.
10.
Gillespie, Michael A., et al.. (2023). A Review of Scheduling Strategies for Radiotherapy and Immune Checkpoint Inhibition in Locally Advanced Rectal Cancer. SHILAP Revista de lepidopterología. 6(4). 187–197. 4 indexed citations
11.
Dolan, Ross D., et al.. (2023). Evaluation of the prognostic value of computed tomography‐derived body composition in patients undergoing endovascular aneurysm repair. Journal of Cachexia Sarcopenia and Muscle. 14(4). 1836–1847. 9 indexed citations
12.
McMillan, Donald C., et al.. (2022). Route to diagnosis of colorectal cancer and association with survival within the context of a bowel screening programme. Public Health. 211. 53–61. 5 indexed citations
13.
14.
McMillan, Donald C., et al.. (2021). The prognostic value of combined measures of the systemic inflammatory response in patients with colon cancer: an analysis of 1700 patients. British Journal of Cancer. 124(11). 1828–1835. 28 indexed citations
15.
Gillespie, Michael A., Colin W. Steele, Tamsin R.M. Lannagan, Owen J. Sansom, & Campbell S.D. Roxburgh. (2021). Pre-clinical modelling of rectal cancer to develop novel radiotherapy-based treatment strategies. Oncology Reviews. 15(1). 511–511. 5 indexed citations
16.
Knight, Katrina, Donald C. McMillan, Paul G. Horgan, et al.. (2021). Vascular calcification and response to neoadjuvant therapy in locally advanced rectal cancer: an exploratory study. Journal of Cancer Research and Clinical Oncology. 147(11). 3409–3420. 2 indexed citations
17.
18.
Roseweir, Antonia K., Kathryn A.F. Pennel, Hester C. van Wyk, et al.. (2020). The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer. British Journal of Cancer. 124(4). 786–796. 14 indexed citations
19.
20.
Park, James H., Donald C. McMillan, Jean A. Quinn, et al.. (2016). Signal Transduction and Activator of Transcription-3 (STAT3) in Patients with Colorectal Cancer: Associations with the Phenotypic Features of the Tumor and Host. Clinical Cancer Research. 23(7). 1698–1709. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dietmar Tamandl Breakdown of academic impact, for papers by Jyrki Mäkelä Breakdown of academic impact, for papers by Mototsugu Shimokawa Breakdown of academic impact, for papers by Reiping Tang Breakdown of academic impact, for papers by Thomas Aparicio Breakdown of academic impact, for papers by Jin‐Tung Liang Breakdown of academic impact, for papers by Martin Rutegård Breakdown of academic impact, for papers by Jungnam Joo Breakdown of academic impact, for papers by Gregory D. Ayers Breakdown of academic impact, for papers by Yasuo Sakamoto
Rankless by CCL
2026